[Ip-health] New Tufts study on R&D costs

Peter Pitts ppitts at cmpi.org
Sat Nov 15 14:27:57 PST 2014


I am going to seek advice from Jonathan Gruber. Please stand by ...

Sent from my iPhone

> On Nov 15, 2014, at 5:15 AM, Dimasi, Joseph A. <Joseph.Dimasi at tufts.edu> wrote:
> 
> Hi Jamie,
> 
> I assume that I can't enter to win the Tufts R&D Cost Estimate Prize Fund, but it's an interesting and amusing crowdsourcing type of experiment.  You might tally the results at the end and show the distribution of predictions.
> 
> Joe
> 
> 
> --
> -----------------------------------------------
> Joseph A. DiMasi, Ph.D.
> Director of Economic Analysis
> Tufts Center for the Study of Drug Development Tufts University
> 75 Kneeland Street, Suite 1100
> Boston, MA 02111
> tel: 617-636-2116; fax: 617-636-2425
> URL: http://csdd.tufts.edu
> -----------------------------------------------
> 
> ________________________________________
> From: Ip-health [ip-health-bounces at lists.keionline.org] on behalf of Jamie Love [james.love at keionline.org]
> Sent: Friday, November 14, 2014 4:14 PM
> To: Outterson, Kevin
> Cc: ip-health at lists.keionline.org listserve
> Subject: Re: [Ip-health] New Tufts study on R&D costs
> 
> It will be interesting to see what "cost of capital" figures Tufts uses
> this year.
> 
> Recently Gilead priced a series of bonds, $500 million at $2.35
> percent maturing February 2020, $1,750M at 3.5 percent maturing February
> 2025 and $1,750M at 4.5 percent maturing February 2045.
> _______________________________________________
> Ip-health mailing list
> Ip-health at lists.keionline.org
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org
> _______________________________________________
> Ip-health mailing list
> Ip-health at lists.keionline.org
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org




More information about the Ip-health mailing list